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Background: The human stomach, when healthy, is not a suitable host for microorganisms, but in pathological
conditions such as gastritis, when gastric acid secretion is impaired, microbial overgrowth can be observed.
Apart from Helicobacter pylori, the composition of microbiota, resident or exogenously introduced during
neutral/high pH conditions, has not been investigated thoroughly. Thus, it is possible that Bifidobacteriaceae,
important autochthonous and beneficial bacteria of human gastrointestinal microbiota, could over-colonize
the stomach of hypochlorhydria patients suffering from autoimmune atrophic gastritis (AAG) or omeprazole-
treated (OME) gastritis. This prompted us to characterize the Bifidobacteriaceae in such patients’ gastric
microbiota and to study its abnormal colonization.
Methods: Samples of gastric juices, and antrum and corpus mucosa from 23 hypochlorhydria patients (13
AAG and 10 OME) and from 10 control volunteers with base-line normochlorhydria, were cultivated in Brain
Heart Infusion (BHI) and selective Bifidobacterium-Tryptone-Phytone-Yeast extract (Bif-TPY) media. The
isolates were characterized by the fructose-6-phosphate phosphoketolase (F6PPK) test, electrophoresis of
cellular proteins, the fermentation test, guanine-cytosine% DNA content, and DNADNA hybridization.
Negative F6PPK isolates were characterized by order-specific polymerase chain reaction (PCR).
Results: A total of 125 isolates, assigned to the Bifidobacteriaceae family on the basis of their morphology,
were obtained from AAG and OME patients, but not from normal subjects. Of these isolates, 55 were
assigned to the Bifidobacteriaceae family on the basis of their fructose-6-phosphoketolase (PPK) activity,
PPK being the key taxonomic enzyme of this family. The remaining 70 isolates, which were PPK-negative,
were attributed to the Actinomycetales order following specific primer PCR analysis. We observed a
significantly higher abundance of Bifidobacteriaceae (Bifidobacterium dentium, Scardovia inopinata, and
Parascardovia denticolens) in OME group than the AAG group. Furthermore, the Actinomycetales
distribution was homogeneous for both hypochlorhydria patient groups.
Conclusions: This study suggests that the Bifidobacteriaceae species, typically found in the oral cavity, readily
colonizes the hypochlorhydria stomach of OME patients. The clinical relevance and the mechanism
underlying this Bifidobacteriaceae presence in OME gastritis requires further functional studies.
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B
ifidobacteriaceae are indigenous components of
human and animal gastrointestinal microbiota and
are routinely isolated from the human gastrointest-
inal tract, especially the colon; they are the first and most
dominant gut inhabitants in early human life. Bifidobac-
teriaceae are also present in the oral cavity and the vagina
(1). Until now, the stomach has been considered an
inhospitable environment for microorganisms because of
its gastric acidity (2). However, recent molecular techni-
ques have revealed that the normal acidic stomach may be
the habitat of a distinct microbial ecosystem, the most
common bacterial phyla being Proteobacteria, Firmicutes,
Bacteroidetes, Actinobacteria, and Fusobacteria, and
the most abundant genera Helicobacter, Streptococcus,
and Prevotella (3). It is known that impaired gastric
acid secretion caused by chronic atrophic gastritis, the
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prolonged use of histamine-2 receptor antagonists or
proton pump inhibitors, can be associated with bacterial
overgrowth in the stomach (4). Apart from Helicobacter
pylori, the composition of the microbiota, resident or
exogenously introduced during neutral/high pH condi-
tions, has not been thoroughly investigated. A recent study
of Dicksved et al. (5) pointed out that acid reducing drug
therapy, corpus atrophy, and gastric cancer can lead to the
microbiota overgrowth being dominated by different
species of the genera Streptococcus, Lactobacillus, Veillo-
nella, and Prevotella. Considering that Bifidobacteriaceae
are components of oral microbiota (6, 7), and that in
conditions of reduced gastric acid secretion bacterial
overgrowth appears related to upstream colonization in
the alimentary tract, it is surprising that so many of the
recently conducted, large-scale studies (3, 5, 8, 9) (but see
also 10) failed to detect Bifidobacteriaceae in the hypo-
chlorhydria stomach microbiota.
The aim of this study was to evaluate, using culture
dependent methods, the Bifidobacteriaceae distribution in
the hypochlorhydria stomach of patients with either




A total of 33 patients (mean age 48.15914.71, range 20
71, 15 men) underwent upper gastrointestinal endoscopy
at around 8.00 a.m. Of these, 23 patients had the
hypochlorhydria condition: 10 with AAG (mean age
43.70919.14 year, range 2071 year, four men) and 13
treated with OME (20 mg/day) for peptic disease (mean
age 52.8599.02 year, range 4270 year, six men). The
control group (mean age 46.5915.41, range 2071 year,
five men) consisted of 10 volunteers with base-line
normochlorhydria (fasting gastric pHB4). All of the
subjects gave their informed written consent to the study,
which involved upper gastrointestinal endoscopy and
biopsy procedures.
Juice and gastric biopsies
A sample of fasting gastric juices (510 ml) was aspirated
at endoscopy using a sterile Teflon cannula inserted into
the biopsy channel of the endoscope. The closed cannula
was opened only after it reaches the gastric lumen. For
the biopsies, six specimens were taken from the gastric
antrum (2 cm proximal to the pylorus) and six from the
corpus (10 cm below the gastroesophageal junction along
the greater curvature) using two different, sterile biopsy
forceps (Olympus FB 24Q-1, Tokyo, Japan). Before each
test, the endoscopes (Olympus GIF 130, Tokyo, Japan)
were disinfected with glutaraldehyde 2% and the biopsy
channel with 70% ethanol; then rinsed with sterile water.
Gastric juice and four biopsies per area were taken to
assess bacterial growth. The gastric juice pH was
measured using a pH-meter (HANNA-8521) with the
microelectrode HI 2031B.
Bacterial isolation
The gastric juice samples and biopsy specimens were
immediately processed for bacteriological evaluation. The
biopsy material was washed with sterile saline solution,
first by gentle hand shaking then harshly by vortex to
avoid bacterial contamination from the gastric fluid. The
biopsy material was then weighed, homogenized, and
diluted in saline solution using a sterile procedure. Each
100 ml aliquot of serial diluted homogenate and gastric
juice (102108) was plated on Brain Heart Infusion
(BHI) agar for anaerobic bacterial growth, and on
selective Bifidobacterium-Tryptone-Phytone-Yeast extract
(Bif-TPY) medium (1) containing 5% propionic acid (pH
5.0) (11) for bifidobacterial growth. The plates were then
incubated anaerobically at 378C for 5 days.
Colonies containing cells with bifidobacterial morphol-
ogy characteristics were picked and subcultured in 0.5%
agar TPY stab anaerobically, at 378C for 24 h. The
isolates were then subcultured in TPY liquid medium
with the same incubation conditions for the identifica-
tion assays. The cells, after centrifugation and addition
of cryoprotective medium (skim milk 20%, lactose 0.3%,
yeast extract 0.3%), were maintained both frozen at
1358C and freeze-dried in the Bologna University
Scardovi Collection of Bifidobacterium (BUSCOB).
Bifidobacteriaceae species identification and
characterization
Morphological features and growth type observations
were performed according to Crociani et al. (12). The
presence of fructose-6-phosphate phosphoketolase (F6PPK)
was determined as described by Biavati and Mattarelli
(1). Species identification was carried out by means of
fermentation tests, polyacrylamide gel electrophoresis
(PAGE) of soluble proteins, and DNADNA homo-
logy. Fermentation tests were performed in TPY liquid
medium as described by Crociani et al. (13). Table 1
shows the 51 tested substrates (simple and complex
carbohydrates, polyalcohols, mucins, and gums). The
PAGE of soluble proteins, DNA base compositions
(GC% contents), and DNADNA homology were
carried out as previously described by, respectively,
Biavati et al. (14), Crociani et al. (12) and Biavati and
Mattarelli (1). Nitrate reduction was determined in a
modified TPY medium containing 0.1% wt/vol of KNO3
and glucose, evidenced by the sulfanilic-naphthylamine
reagent (15).
Actinomycetales group identification
Phosphoketolase negative isolates were tested by primer-
specific polymerase chain reaction (PCR), to identify the
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Actinomycetales order; DNA was extracted according to
Rossi et al. (16). A pair of universal primers designed for
the order of Actinomycetales and the PCR procedure,
described by Xia and Baumgartner (17), was used to
identify the isolates. The PCR-positive controls were
done with DSM 43327T Actinomyces viscosus, and the
negative ones with double-distilled water.
Statistical analysis
Parametric results were reported as means with SD. A
statistical comparison was made between the detection
rate of Bifidobacteriaceae and Actinomycetales groups
and stomach hypochlorhydria in OME and AAG sub-
jects, performed using Fisher’s exact test. pB0.05 was
considered significant.
Results
Table 2 shows the demographic and clinical character-
istics of the 33 subjects classified according to pathology
and gastric pH.
pH and anaerobic microbial growth
The gastric pH was significantly lower in the acid
controls (0.9090.6) than in the AAG and OME groups
(7.4290.5 and 7.1290.8, respectively) (pB0.01), while
the OME and AAG groups showed no significant
difference (p0.05) (Table 2). All of the examined
subjects showed a significant positive correlation between
gastric pH and total bacterial count (r20.89; pB0.01),
higher microbial counts being evident in the high pH
stomach (Table 3).
Samples from antrum and corpus biopsies, and from
gastric juice, were analyzed. Anaerobe growth in BHI
broth was detected in all the samples from the AAG and
OME subjects, but not from the acid controls (Table 3).
Bifidobacteriaceae and Actinomycetales strains in
the hypochlorhydria stomach
Isolates were obtained from Bif-TPY and BHI agar plates
(45 and 80 colonies, respectively) containing cells with
bifidobacterial morphological characteristics. The test for
Table 1. Fermentative characteristics of the Bifidobacteriaceae strains isolated from the hypochlorhydria stomacha
Species
Substrate P. denticolens S. inopinata B. dentium B. infantis-longum Unidentified strain
34b
14 5 1 1
Amylopectin     
Amylose     
L-Arabinose  (3)c    
Cellobiose  (1)  (1)   
Dextran  (2)   (1)  
Dextrin     
Galactose   (1)   
Glycerol   (1)   
D-Glucosamine     
Gum guar     
Gum locust bean     
Inulin   (1)   
Mannitol     
Mannose     
Melezitose  (4)  (2)   
Raffinose  (3)    
Salicin  (1)  (7)   
Trehalose     
D-Xylose  (4)  (1)   
, positive reaction; , negative reaction.
aAll strains fermented glucose, fructose, lactose, melibiose, maltose, ribose, sucrose, starch. None of the strains fermented alginate,
arabinogalactan, bovine submaxillary mucin, chondroitin sulfate, D-fucose, L-fucose, D-galactosamine, alpha-D-galacturonate, gluconate,
D-glucuronate, gum arabic, gum ghatti, gum karaya and gum tragacanth, L-hyaluronate, lactate, laminarin, ovomucoid, pectin,
polygalacturonate, porcine gastric mucin, L-rhamnose, sorbitol, xylan.
bNumber of strains tested.
cIn parenthesis, the number of strains with the opposite reaction.
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F6PPK, the key enzyme of the glucose catabolic pathway
in the Bifidobacteriaceae family, was positive in all 45
isolates from selective Bif-TPY medium, and in 10 of the
80 isolates from BHI. Surprisingly, despite their typical
bifidobacterial morphology (Fig. 1), the remaining 70
isolates from BHI (all F6PPK negative) did not belong to
Bifidobacteriaceae. Thus, based on PCR analysis, and
using a specific primer for Actinomycetales, they were
presumptively assigned to the Actinomycetales order.
To sum up, 55 Bifidobacteriaceae and 70 Actinomyce-
tales isolates were obtained from the 23 hypochlorhydria
subjects. The 55 Bifidobacteriaceae isolates came from 2
of the 10 samples of AAG subjects, and from 7 of the 13
OME subjects, while the 70 Actinomycetales isolates came
from 9 of the 10 AAG subjects and 11 of the 13 OME
subjects (Table 2). For both AAG and OME patients,
there was no correlation between the presence of
Bifidobacteriaceae and Actinomycetales with respect to
sex and patient age. However, there was a significant
correlation between Actinomycetales presence and the
AAG and OME patients (pB0.01), while the Bifidobac-
teriaceae presence correlated significantly only with the
OME patients (pB0.01).
Bifidobacteriaceae identification
The 55 Bifidobacteriaceae isolates underwent phenotype
and genotype analyses that took into consideration cell
morphology (Fig. 2), electrophoresis PAGE, fermenta-
tion, DNA GC% contents and DNADNA homology
analysis. All the utilized techniques consistently resulted
in the same isolate grouping. These 55 Bifidobacteriaceae
isolates were found to belong to three prevalent species,
B. dentium (five isolates), Scardovia inopinata (14 iso-
lates), Parascardovia denticolens (34 isolates) (Table 4),
while one OME juice isolate belonged to the B. infantis-
longum group, its homology value being 68 and 71%
compared to the B. longum subsp. longum and B. longum
subsp. infantis species, respectively. One OME antrum
isolate, BR 191, failed to hybridize with any of the
Bifidobacteriaceae species described to date (data not
shown), so further analyses are needed to verify its
belonging to a new species. Its DNA GC content was
43%, one of the lowest in the Bifidobacteriaceae family;
the intraspecific DNADNA homology range was 85
100%, whereas the interspecific was 515%.
The DNA GC content of P. denticolens, B. dentium,
and S. inopinata was 5791 mol%, 6091 mol%, and 469
1 mol%, respectively, consistent with the assigned species
(12). Table 1 shows the fermentation characteristics of the
isolates in the different substrates assayed. Some pheno-
types of the stomach isolates differed from those of the
oral cavity. We found that P. denticolens fermented
melezitose, S. inopinata fermented galactose but not
salicin, and B. dentium did not ferment gluconate: these
fermentative characteristics are completely out of line
with those of oral cavity isolates of the same species.
All Bifidobacteriaceae isolates were nitrate reduction
negative.
Discussion
The study describes the total anaerobic microbial growth,
and the presence of Bifidobacteriaceae and Actinomyce-
tales, in paired gastric biopsies (antrum and corpus) and
the gastric juices of OME and AAG patients and normal
subjects.
Anaerobic microbial growth was found to be signifi-
cantly higher in OME and AAG subjects, and absent in
normal subjects. There was a significantly higher abun-
dance of Bifidobacteriaceae with the species Bifidobacter-
ium dentium, Scardovia inopinata, and Parascardovia
denticolens in the OME patients, with respect to the
AAG. Furthermore, the distribution of Actinomycetales
was more homogeneous and was significantly correlated
with the OME and AAG subjects, while Bifidobacteria-
ceae presence is significant only for the OME patients.
Table 2. Demographic and clinical characteristics of the 33 subjects studied
AAG OME Acid control
Number of subjects 10 13 10
Sex (M/F) 4/6 6/7 5/5
Age (mean years9SD) 43.7919.1 52.999.0 46.5915.4
pH juice (mean9SD) 7.1290.8 7.4190.5 0.990.6
Patient with Bifidobacteriaceae only 1 2 0
Patients with Actinomycetales only 8 6 0
Patients with both Bifidobacteriaceae and Actinomycetales 1 7 0
Table 3. Anaerobic microorganisms grown on BHI in gastric
juice and mucosa of the stomacha
Gastric juiceb Antrumb Corpusb
AAG (10) 6.9490.3 6.5190.3 6.8690.2
OME (13) 5.9390.3 5.4390.4 5.1590.5
aIn the acid control group, there is no bacterial growth in any
sample (gastric juice and antrum and corpus mucosa)
bMean bacterial count expressed as log10 values of CFU/g or ml.
Paola Mattarelli et al.
4
(page number not for citation purpose)
Citation: Microbial Ecology in Health & Disease 2014, 25: 21379 - http://dx.doi.org/10.3402/mehd.v25.21379
The strong relationship between high gastric pH and
Bifidobacteriaceae presence, in greater amounts in OME
patients than in AAG, could be due to the fact that the
high gastric pH of OME patients can decrease during the
day, whereas in AAG patients the pH is constantly high
(18). Moreover, in OME, Bifidobacteriaceae, which are
acidophilic microorganisms, have a higher survival rate
because of the varying pH levels. This is the first time that
a Bifidobacteriaceae population has been studied at the
species level in hypochlorhydria stomach: the three
species found were B. dentium, P. denticolens, and S.
inopinata, typical of the oral cavity (7), with only two
isolates belonging to different species, one to B. infantis-
longum (bifidobacterial species typical of gut microbiota)
and the other to an unidentified Bifidobacteriaceae spp.
The main scope of the work was to assess the presence of
bifidobacteria in hypochlorhydria stomach, but, as a
serendipitous finding, we also found a relevant presence
of bacteria belonging to the Actinomycetales order, an
important component of oral microbiota (19, 20). The
presence of Bifidobacteriaceae and Actinomycetales sup-
ports the hypothesis that a prevalent source of stomach
bacteria could be the microbiota of the oral cavity, rather
than bacteria from an intestinal habitat (3). Indeed, it is
well known that bacteria from the oral cavity can
colonize the stomach if the environmental conditions
are favorable (21), and such conditions are certainly
favorable in the case of hypochlorhydria in AAG and
OME patients.
However, previous important studies on gastric hypo-
chlorhydria failed to detect Bifidobacteriaceae (3, 8),
which is quite surprising. This could have been due to
the use of the primer that is mostly used in 16S rRNA
sequences; this primer has mismatches with the sequence
of Bifidobacteriaceae (22, 23).
The same failure concerns Actinobacteria, mainly
represented by bifidobacteria. In fact, Actinobacteria
are under-represented in gut phylogenetic descriptions
(24), though their active presence has been evidenced
(25). The same problem arises in oral microbiota studies:
Bifidobacteriaceae are routinely isolated from human oral
cavity and saliva by classic culture methods, and also by
molecular techniques (6, 7), but extensive recent work
based on pyrosequencing and microarray assay failed to
reveal Bifidobacteriaceae in the oral microbioma (26, 27).
Our study shows that Bifidobacteriaceae are evidenced
if the appropriate methodology is used, especially in
OME gastritis patients.
With regard to human health, studies on gut micro-
biota have gained in importance, with emerging evi-
dence that demonstrates the role of such microbiota in
disease (2832). Of particular interest is the presence of
the bifidobacteria, considered probiotic microorganisms
useful to the host for their very beneficial activity (33).
Fig. 1. Morphology of Actinomycetales isolates: a, BR183; b, BR193; c, BR431. Phase-contrast microphotographs.
Fig. 2. Morphology of Bifidobacteriaceae isolates. S. inopinata: a, BR134; b, BR203. P. denticolens: c, BR278; d, BR281. B. dentium: e,
BR317; f, BR318. B. infantis-longum: g, BR184. Unidentified Bifidobacteriaceae: h, BR191.
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The exact role of Bifidobacteriaceae in gastritis is still to
be investigated (34, 35). The results of this study suggest
that the healthy stomach does not harbor bifidobacteria,
so their presence is not foreseen under normal conditions.
Therefore, it is obviously desirable that the gastric
microbiota remain at normal values, but altered physio-
logical conditions such as gastritis, Helicobacter pylori
infection, autoimmune pathology, gastroduodenal ulcers,
neoplastic lesions, etc., do not allow this, and microbiota
can remain altered for long periods of time (36). This
raises the question: Could this atypical overgrowth of
gastric microbiota eventually result in a protective or
negative role for the host?
One of the answers could deal with the following
consideration: in hypochlorhydria, there are reduced
levels of gastric juice vitamin C, which is normally
secreted by healthy mucosa to inhibit the bacterial
synthesis of nitrites to N-nitroso compounds (37),
and increased levels of nitrites, the source of carcinogenic
N-nitroso compounds (38). Thus, the presence of bifido-
bacteria in the hypochlorhydria stomach could be
beneficial, helping to reduce nitrite concentrations de-
rived from bacterial metabolism and/or from saliva (39)
as it modulates the nitrites through acid production by its
modulation through acid production (40).
Conclusions
Our study suggests that Bifidobacteriaceae species dis-
tributed in the oral cavity habitat can colonize, to quite a
large degree, the OME-treated hypochlorhydria stomach.
This is a finding that offers a starting point, one requiring
further functional studies, to assess the clinical relevance
of Bifidobacteriaceae in the stomach, and to gain a better
understanding of the mechanism underlying Bifidobac-
teriaceae occurrence in OME-treated gastritis. The intri-
guing question is whether this atypical microbiota
colonization exerts positive or negative effect on the host.
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